title: Commentary on Garbutt et al. (2014): Can we predict who benefits from naltrexone in the treatment of alcohol dependence?
authors.affiliation: Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA; VISN 4 Mental Illness Research, Education, and Clinical Center, Philadelphia VA Medical Center, Philadelphia, PA, USA. kranzler@mail.med.upenn.edu.
authors.forename: Henry R
authors.initials: HR
authors.lastname: Kranzler
mesh_terms: D000437:Alcoholism / Q000188:drug therapy*; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D009292:Narcotic Antagonists; D009271:Naltrexone
keywords: Clinical predictors; critical review; family history of alcoholism; moderators; naltrexone; pharmacogenetics